On-demand male contraception via acute inhibition of soluble adenylyl cyclase

Author:

Balbach Melanie,Rossetti Thomas,Ferreira Jacob,Ghanem Lubna,Ritagliati Carla,Myers Robert W.,Huggins David J.,Steegborn ClemensORCID,Miranda Ileana C.ORCID,Meinke Peter T.,Buck JochenORCID,Levin Lonny R.ORCID

Abstract

AbstractNearly half of all pregnancies are unintended; thus, existing family planning options are inadequate. For men, the only choices are condoms and vasectomy, and most current efforts to develop new contraceptives for men impact sperm development, meaning that contraception requires months of continuous pretreatment. Here, we provide proof-of-concept for an innovative strategy for on-demand contraception, where a man would take a birth control pill shortly before sex, only as needed. Soluble adenylyl cyclase (sAC) is essential for sperm motility and maturation. We show a single dose of a safe, acutely-acting sAC inhibitor with long residence time renders male mice temporarily infertile. Mice exhibit normal mating behavior, and full fertility returns the next day. These studies define sAC inhibitors as leads for on-demand contraceptives for men, and they provide in vivo proof-of-concept for previously untested paradigms in contraception; on-demand contraception after just a single dose and pharmacological contraception for men.

Funder

U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Soluble adenylyl cyclase, the cell-autonomous member of the family;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

2. Advances in Male Contraception: When Will the Novel Male Contraception be Available?;The World Journal of Men's Health;2024

3. Male Contraception;Seminars in Reproductive Medicine;2023-12-19

4. Nonhormonal Male Contraceptive Development—Strategies for Progress;Pharmacological Reviews;2023-11-30

5. Male contraception: narrative review of ongoing research;Basic and Clinical Andrology;2023-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3